Delivery Order SPE2DB20D9103-SPE2DB24FE7A8
Award Date
12/20/23
Potential Completion Date
1/12/24
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG implants. The order has a completion date of January 30, 2024 and a potential value of $7,146.90. This delivery order is part of a larger indefinite delivery contract DMS Pharmaceutical Group holds with DLA Troop Support Medical to provide a variety of pharmaceutical items and medical supplies to support military treatment...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $17,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 68 mg NEXPLANON contraceptive implants. This delivery order falls under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has no...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,181,463 units of the contraceptive implant NEXPLANON 68 MG. The $8,204.88 delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. to supply pharmaceuticals and medical products to DLA Troop Support Medical facilities worldwide. The contract does not have a set-aside designation and has a...
The U.S. Defense Logistics Agency (DLA) awarded a $25,728.84 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of 4,565,176,099 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which runs through December 31, 2025. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,564,134,203 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. This order was placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, valued at up to $4,999,999 through 2025. The DLA utilizes this vehicle to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of NEXPLANON 68 MG IMPLANTS. The contract has a ceiling value of $2,082.93 and an ultimate completion date of February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. valued at $499,999,999, which enables the DLA to issue...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of NEXPLANON 68 MG IMPLANTS. The $42,881.40 contract has an ultimate completion date of October 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply NEXPLANON 68 MG IMPLANTS. The order has a potential value of $2,858.76 and a completion date of January 30, 2024. This delivery order is issued against a larger indefinite delivery contract with DLA Troop Support Medical to provide various pharmaceutical and medical supplies to support military treatment facilities worldwide....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 68 mg NEXPLANON contraceptive implants. The $14,293.80 order has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple DLA contracts and indefinite delivery vehicles to supply a variety of medical items and pharmaceuticals to military treatment facilities worldwide. This...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The $7,146.90 delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products to military treatment facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on...